News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genmab A/S (GEN.CO) Release: First Quarter 2014 Net Sales Figures For Arzerra



4/30/2014 9:49:53 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Copenhagen, Denmark; April 30, 2014 – Genmab A/S (OMX: GEN) announced today that net sales of Arzerra (ofatumumab) during the first quarter of 2014 were GBP 15.6 million (approximately DKK 140 million). This figure consists of net sales in the US of GBP 10.1 million and in the rest of the world of GBP 5.5 million. Under the terms of the collaboration with GlaxoSmithKline (GSK), Genmab expects to receive a royalty payment of approximately DKK 28 million.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES